Eugenics by the back door? The unintended consequences of restricting people's choices about mental health medicines.
Jones
M
M
Surrey and Borders Partnership Foundation NHS Trust, Frimley, Surrey, UK.
Lancashire
S
S
Gurney
S
S
Gray
R
R
D014150:Antipsychotic Agents / Q000191:economics / Q000627:therapeutic use*; D002755:Choice Behavior; D016527:Drug Costs; D011307:Drug Prescriptions / Q000191:economics / Q000451:nursing; D016568:Drugs, Generic / Q000191:economics / Q000627:therapeutic use; D005053:Eugenics; D006287:Health Planning Guidelines; D006291:Health Policy; D006297:Health Services Accessibility / Q000458:organization & administration; D006801:Humans; D010344:Patient Advocacy; D011568:Psychiatric Nursing / Q000458:organization & administration*; D018967:Risperidone / Q000191:economics / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy / Q000451:nursing; D013222:State Medicine / Q000458:organization & administration; D006113:United Kingdom
D014150:Antipsychotic Agents; D016568:Drugs, Generic; D018967:Risperidone